Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer

Gynecologic Oncology

Volumn 85, Issue 3, 2002, Pages 431-434

  Levine, Douglas A ^a   Federici, Mark G ^a   Reuter, Victor E ^a   Boyd, Jeff ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Apoptosis; BRCA; Cell proliferation; Hereditary; Ovarian cancer

Indexed keywords

KI 67 ANTIGEN;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CELL GROWTH; CELL PROLIFERATION; CYTOTOXICITY; FAMILIAL CANCER; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; ONCOGENE; OVARY CANCER; PRIORITY JOURNAL;

EID: 0036080670     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6646     Document Type: Article

References (20)

1. Molecular genetics of hereditary ovarian cancer
2. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer
3. Clinical and pathologic features of ovarian cancer in women with germ-line mutations of BRCA1
4. Clinical features of ovarian cancer in Japanese women with germ-line mutations of BRCA1
5. Survival in epithelial ovarian cancer patients with prior breast cancer
6. Principles of chemotherapy
7. Absence of premalignant histologic, molecular, or cell biological alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes
8. Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases
9. Tumour biological features of BRCA1-induced breast and ovarian cancer
10. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations
11. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage
12. BRCA-associated breast cancer: Absence of a characteristic immunophenotype
13. Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcnioma in Japanese women
14. Hereditary breast cancer
15. Epithelial ovarian cancer
16. In search of the tumour-suppressor functions of BRCA1 and BRCA2
17. Insights into the functions of BRCA1 and BRCA2
18. The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
19. Role of BRCA1 in response to therapeutic DNA-damaging agents in human breast cancer cells
20. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II)